Social, cultural and economic aspects of antimicrobial resistance
(2020) In Bulletin of the World Health Organization 98(12). p.823-824- Abstract
- "The COVID-19 pandemic has taught us the terrible cost of being unprepared for global health emergencies. The lack of treatments, vaccines, and sufficiently coordinated responses resulted in many unprecedented challenges that must now be analyzed and tackled rapidly. The crisis has raised awareness of the urgent need to improve the design of health systems, as well as the practical implementation of new strategies and technical solutions to better prepare for future pandemics. These preparations must also consider harms secondary to the pandemic, including the resulting effects on antimicrobial resistance (AMR). While drug-resistant infections pose a well-known and severe threat to human and animal health, the COVID-19 pandemic is... (More)
- "The COVID-19 pandemic has taught us the terrible cost of being unprepared for global health emergencies. The lack of treatments, vaccines, and sufficiently coordinated responses resulted in many unprecedented challenges that must now be analyzed and tackled rapidly. The crisis has raised awareness of the urgent need to improve the design of health systems, as well as the practical implementation of new strategies and technical solutions to better prepare for future pandemics. These preparations must also consider harms secondary to the pandemic, including the resulting effects on antimicrobial resistance (AMR). While drug-resistant infections pose a well-known and severe threat to human and animal health, the COVID-19 pandemic is compounding this already problematic situation. Although often considered only a medical problem, antimicrobial resistance is an evolutionary challenge accelerated by social, cultural and economic factors that lead to the misuse, overuse and abuse of life-saving antimicrobial medicines. The antimicrobial resistance challenge is compounded by inadequate attention to disease prevention and response, global circulation of people and products, differences in industry and market regulations across countries, and a fragile pipeline of new antibiotics and their alternatives. While the discovery of new antimicrobials will provide temporary solutions, sustainable success requires rigorous social science research that explores the drivers of antimicrobial resistance. These solutions should promote balance between equitable access to, conservation of, and innovation for antimicrobials, adapted to local conditions across the globe. To encourage collaboration and to address this challenge, we have created the International Network for Antimicrobial Resistance Social Science (INAMRSS).12 The network is an open consortium of social science researchers focused on addressing the global challenge of antimicrobial resistance. We believe antimicrobial resistance is only surmountable through efforts that consider social, political and economic factors. We intend to champion social science as part of a broadly defined One Health perspective to inform global initiatives. INAMRSS is a member of the Global AMR R&D Hub stakeholder group, which has built a system to track antimicrobial resistance research investment, but has not yet started monitoring relevant social science research funding. We endorse the recommendation of the United Nations Interagency Coordination Group on Antimicrobial Resistance for creating an Independent Panel on Evidence for Action against such resistance, with appropriate expertise across disciplines including the social sciences, and with a focus on the ways that humans are driving this problem and can contribute to solutions" (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/d0d0b205-504d-4d4b-adf7-4aa262221f4f
- author
- publishing date
- 2020-12-03
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Faculty of Law, social science, antimicrobial resistance, innovation, access, conservation, law, economics, medicine, behavioral science, Medical law, Medicinsk rätt
- in
- Bulletin of the World Health Organization
- volume
- 98
- issue
- 12
- pages
- 2 pages
- publisher
- World Health Organization
- external identifiers
-
- scopus:85097025561
- ISSN
- 0042-9686
- DOI
- 10.2471/BLT.20.001220
- language
- English
- LU publication?
- no
- id
- d0d0b205-504d-4d4b-adf7-4aa262221f4f
- date added to LUP
- 2020-12-16 13:03:04
- date last changed
- 2022-04-26 22:36:53
@article{d0d0b205-504d-4d4b-adf7-4aa262221f4f,
abstract = {{"The COVID-19 pandemic has taught us the terrible cost of being unprepared for global health emergencies. The lack of treatments, vaccines, and sufficiently coordinated responses resulted in many unprecedented challenges that must now be analyzed and tackled rapidly. The crisis has raised awareness of the urgent need to improve the design of health systems, as well as the practical implementation of new strategies and technical solutions to better prepare for future pandemics. These preparations must also consider harms secondary to the pandemic, including the resulting effects on antimicrobial resistance (AMR). While drug-resistant infections pose a well-known and severe threat to human and animal health, the COVID-19 pandemic is compounding this already problematic situation. Although often considered only a medical problem, antimicrobial resistance is an evolutionary challenge accelerated by social, cultural and economic factors that lead to the misuse, overuse and abuse of life-saving antimicrobial medicines. The antimicrobial resistance challenge is compounded by inadequate attention to disease prevention and response, global circulation of people and products, differences in industry and market regulations across countries, and a fragile pipeline of new antibiotics and their alternatives. While the discovery of new antimicrobials will provide temporary solutions, sustainable success requires rigorous social science research that explores the drivers of antimicrobial resistance. These solutions should promote balance between equitable access to, conservation of, and innovation for antimicrobials, adapted to local conditions across the globe. To encourage collaboration and to address this challenge, we have created the International Network for Antimicrobial Resistance Social Science (INAMRSS).12 The network is an open consortium of social science researchers focused on addressing the global challenge of antimicrobial resistance. We believe antimicrobial resistance is only surmountable through efforts that consider social, political and economic factors. We intend to champion social science as part of a broadly defined One Health perspective to inform global initiatives. INAMRSS is a member of the Global AMR R&D Hub stakeholder group, which has built a system to track antimicrobial resistance research investment, but has not yet started monitoring relevant social science research funding. We endorse the recommendation of the United Nations Interagency Coordination Group on Antimicrobial Resistance for creating an Independent Panel on Evidence for Action against such resistance, with appropriate expertise across disciplines including the social sciences, and with a focus on the ways that humans are driving this problem and can contribute to solutions"}},
author = {{Minssen, Timo and Outterson, Kevin and Van Katwyk, Susan Rogers and Batista, Pedro Henrique D. and Chandler, Clare and Ciabuschi, Francesco and Harbarth, Stephan and Kesselheim, Aaron and Laxminarayan, Ramanan and Liddell, Kathleen and Osterholm, Michael T. and Price, Lance and Hoffman, Steven J.}},
issn = {{0042-9686}},
keywords = {{Faculty of Law; social science; antimicrobial resistance; innovation; access; conservation; law; economics; medicine; behavioral science; Medical law; Medicinsk rätt}},
language = {{eng}},
month = {{12}},
number = {{12}},
pages = {{823--824}},
publisher = {{World Health Organization}},
series = {{Bulletin of the World Health Organization}},
title = {{Social, cultural and economic aspects of antimicrobial resistance}},
url = {{http://dx.doi.org/10.2471/BLT.20.001220}},
doi = {{10.2471/BLT.20.001220}},
volume = {{98}},
year = {{2020}},
}